(2E)-3-(4-hydroxyphenyl)-2-[(oxan-2-yloxy)imino]propanoic acid | 958255-24-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 苯丙酸
• 英文名称: (2E)-3-(4-hydroxyphenyl)-2-[(oxan-2-yloxy)imino]propanoic acid
• 英文别名: (2E)-3-(4-hydroxyphenyl)-2-(oxan-2-yloxyimino)propanoic acid
• CAS: 958255-24-8
• 化学式: C₁₄H₁₇NO₅
• 分子量: 279.293
• InChiKey: CFTZBIWJKQIXRS-NTCAYCPXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  88.4
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (2E)-3-(4-hydroxyphenyl)-2-[(oxan-2-yloxy)imino]propanoic acid 在 盐酸 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 三乙胺 作用下， 以 1,4-二氧六环 、 甲醇 、 乙醚 、 二氯甲烷 为溶剂， 反应 16.0h， 生成 (2E,2′E)-N,N’-(disulfanediylbis(ethane-2,1-diyl))bis(2-(hydroxyimino)-3-(4-hydroxyphenyl)propanamide)
  参考文献：
  名称：

  Combinatorial Synthesis through Disulfide Exchange: Discovery of Potent Psammaplin A Type Antibacterial Agents Active against Methicillin-ResistantStaphylococcus aureus (MRSA)

  摘要：

  Psammaplin A is a symmetrical bromotyrosine -derived disulfide natural product isolated from the Psammaplysilla sponge, which exhibits in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). Inspired by the structure of this marine natural product, a combinatorial scrambling strategy for the construction of heterodimeric disulfide analogues was developed and applied to the construction of a 3828-membered library starting from 88 homodimeric disulfides. These psammaplin A analogues were screened directly against various gram positive bacterial strains leading to the discovery of a series of potent antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA), Among the most active leads derived from these studies are compounds 104. 105, 113, 115, 123, and 128. The present, catalytically-induced. disulfide exchange strategy may be extendable to other types of building blocks bearing thiol groups facilitating the construction of diverse discovery-oriented combinatorial libraries.

  DOI：

  10.1002/1521-3765(20011001)7:19<4280::aid-chem4280>3.0.co;2-3
• 作为产物：
  描述：

  L-酪氨酸 在 三氟乙酸 作用下， 以 乙醇 为溶剂， 反应 48.0h， 生成 (2E)-3-(4-hydroxyphenyl)-2-[(oxan-2-yloxy)imino]propanoic acid
  参考文献：
  名称：

  Combinatorial Synthesis through Disulfide Exchange: Discovery of Potent Psammaplin A Type Antibacterial Agents Active against Methicillin-ResistantStaphylococcus aureus (MRSA)

  摘要：

  Psammaplin A is a symmetrical bromotyrosine -derived disulfide natural product isolated from the Psammaplysilla sponge, which exhibits in vitro antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). Inspired by the structure of this marine natural product, a combinatorial scrambling strategy for the construction of heterodimeric disulfide analogues was developed and applied to the construction of a 3828-membered library starting from 88 homodimeric disulfides. These psammaplin A analogues were screened directly against various gram positive bacterial strains leading to the discovery of a series of potent antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA), Among the most active leads derived from these studies are compounds 104. 105, 113, 115, 123, and 128. The present, catalytically-induced. disulfide exchange strategy may be extendable to other types of building blocks bearing thiol groups facilitating the construction of diverse discovery-oriented combinatorial libraries.

  DOI：

  10.1002/1521-3765(20011001)7:19<4280::aid-chem4280>3.0.co;2-3

文献信息

• Carbonic Anhydrase XII Inhibitors Overcome Temozolomide Resistance in Glioblastoma
  作者：Prashant Mujumdar、Joanna Kopecka、Silvia Bua、Claudiu T. Supuran、Chiara Riganti、Sally-Ann Poulsen

  DOI：10.1021/acs.jmedchem.9b00282

  日期：2019.4.25

  C (1), when used in combination with clinically used chemotherapeutic drugs, including temozolomide, reverses multidrug resistance and increases survival in glioblastoma, a highly aggressive primary brain tumor. We showed previously that the mechanism of action of 1 is novel, acting to indirectly interfere with P-glycoprotein drug efflux activity as a consequence of carbonic anhydrase XII (CA XII) inhibition

  天然产物初级磺酰胺，psammaplin C（1）与临床使用的化疗药物（包括替莫唑胺）组合使用时，可以逆转多药耐药性并增加成胶质母细胞瘤（一种高度侵袭性原发性脑肿瘤）的存活率。我们以前表明1的作用机理是新颖的，其作用是由于碳酸酐酶XII（CA XII）抑制而间接干扰P-糖蛋白药物外排活性。为了建立构效关系，设计，合成了1的45个衍生物，并针对一组CA同工型进行了评估。化合物55被确定为CA XII的有效抑制剂（Ki = 0.56 nM），并使用胶质母细胞瘤患者的样品进行了体内和体外研究。
• Total synthesis of a dibromotyrosine alkaloid inhibitor of mycothiol S-conjugate amidase
  作者：Andrew S. Kende、Jiong Lan、Junfa Fan

  DOI：10.1016/j.tetlet.2003.10.117

  日期：2004.1

  sequences are described for the first total synthesis of a dibromotyrosine alkaloid (1) reported to inhibit a critical mycobacterial enzyme, mycothiol S-conjugate amidase. The O-benzyloxime of 4-hydroxyphenylpyruvic acid was dibrominated and successively linked to a 3-aminopropyl chain, then to a 4-aminobutylguanidine unit, followed by selective deprotections to yield alkaloid 1. In an improved variant, the

  描述了两个互补的合成序列，用于首次完全合成二溴酪氨酸生物碱（1），据报道该生物碱可以抑制关键的分枝杆菌酶，分枝硫醇S-共轭酰胺酶。将4-羟基苯基丙酮酸的O-苄基肟二溴化，并先后连接至3-氨基丙基链，然后至4-氨基丁基胍单元，然后进行选择性脱保护，得到生物碱1。在改进的变体中，将O-四氢吡喃基肟12与4-氨基丁基胍缩合，然后二溴化成苯酚14，其在Mitsunobu偶联至3-氨基丙基链段并脱保护后生成靶标1。
• Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets
  作者：Matthias G. J. Baud、Thomas Leiser、Patricia Haus、Sharon Samlal、Ai Ching Wong、Robert J. Wood、Vanessa Petrucci、Mekala Gunaratnam、Siobhan M. Hughes、Lakjaya Buluwela、Fabrice Turlais、Stephen Neidle、Franz-Josef Meyer-Almes、Andrew J. P. White、Matthew J. Fuchter

  DOI：10.1021/jm2016182

  日期：2012.2.23

  Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC50 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotcodcity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor.